Literature DB >> 9413042

Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I.

T Murata1, S Nakamura, H Kato, Y Yatabe, T Shiraishi, M Kuroda, R Yatani, T Suchi.   

Abstract

A case of Hodgkin's disease (HD), lymphocyte depression (LD) type in an immunosuppressive patient is described. The patient was a 48-year-old male and his parents were born in the Kyushu area, which is an endemic area for adult T cell lymphoma/leukemia (ATL). He was seropositive for ATL virus (ATLV, also referred to as HTLV-I) and showed a marked immunosuppressive condition. He developed LD-HD and Pneumocystis carinii pneumonia, and died due to respiratory failure. The immunohistochemical and in situ hybridization analyses revealed that the Reed-Sternberg-like cells in the lymph node biopsy sample were positive for Ber-H2 (CD30), Leu-M1 (CD15), L-26 (CD20), Bcl-2, p53 and EBER, the viral genome of Epstein-Barr virus (EBV).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413042     DOI: 10.1111/j.1440-1827.1997.tb04461.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Clinical and cytopathological characteristics of HTLV-1+ hodgkin lymphoma.

Authors:  Katsumi Kobata; Shoichi Kimura; Yasuhito Mihashi; Hiromi Iwasaki; Shuichi Nonaka; Shinji Matsumoto; Yasushi Takamatsu; Ilseung Choi; Shigeto Kawauchi; Kenji Ishitsuka; Morishige Takeshita
Journal:  Cancer Med       Date:  2020-06-28       Impact factor: 4.452

2.  EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier.

Authors:  Brady Beltran; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Esther Cotrina; Luis Riva; Jorge Castillo
Journal:  Infect Agent Cancer       Date:  2009-07-06       Impact factor: 2.965

3.  Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers.

Authors:  Brady E Beltran; Pilar Quiñones; Domingo Morales; Jose C Revilla; Jose C Alva; Jorge J Castillo
Journal:  Leuk Res Treatment       Date:  2011-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.